Article Sidebar

Submitted
Mar 24, 2022
Published
Feb 21, 2023
Download
Pdf
Statistic
Read Counter : 267 Download : 268

Downloads

Download data is not yet available.

Main Article Content

Abstract

The province that ranks fourth with the highest incidence of hypertension in Indonesia is the Special Region of Yogyakarta (DIY). Hypertension therapy is carried out in a not short period, so it becomes an economic burden for people with hypertension and the government. This study aims to determine the relationship between the length of hospitalization and direct medical costs—an analytical observational research method with retrospective data collection and data from class III inpatient hypertensive medical records. The calculation of costs is viewed from a payer's perspective—descriptive and analytical data analysis to determine the relationship between the length of hospitalization and direct medical costs. The study's results of 41 patients met the criteria; 53.65% were women aged 22-59 years (53.65%). The most widely used antihypertensive drug was the combination of amlodipine + candesartan (26.82%). The average direct medical costs for hypertensive patients were IDR 7,039,515. The highest direct medical cost component is the cost of other drugs and medical equipment. The component of direct medical costs is the lowest cost of antihypertensive drugs. The average length of hospitalization for hypertensive patients is 6.14 days. There was a significant relationship (p=0.000) between the length of hospitalization and direct medical costs. The conclusion of this study is a significant relationship (p = 0.000) between the length of hospitalization and direct medical costs

Keywords

Direct medical cost Length of stay Hypertension

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

References

  1. Adane, E., Atnafu, A., & Aschalew, A. Y. (2020). The Cost of Illness of Hypertension and Associated Factors at the University of Gondar Comprehensive Specialized Hospital Northwest Ethiopia, 2018. Clinico Economics and Outcomes Research, 12, 133–140.
  2. Amanda, D., & Martini, S. (2018). Hubungan Karakteristik dan Obesitas Sentral dengan Kejadian Hipertensi. Jurnal Berkala Epidemiolog, 6(1), 43–50.
  3. Amiman, R. C., Tumboimbela, M. J., & Kembuan, M. A. H. N. (2016). Gambaran length of stay pada pasien stroke rawat inap di RSUP Prof. Dr.Kandou Manado Periode Juli 2015-Juni 2016. Jurnal E-Clinic (ECl), 4(2), 1–7.
  4. Bambungan, Y. M., Oetari, R. ., & Satibi. (2017). Analisis Biaya Pengobatan Hipertensi pada Pasien Hipertensi Rawat Inap di RSUD Sorong. Tunas Tunas Riset Kesehatan, VII(2), 72–76.
  5. Baroroh, F., & Fatonah, S. S. (2017). Biaya Medik Langsung Terapi Hipertensi Pasien Rawat Jalan di Rumah Sakit X Yogyakarta. Jurnal Farmasi Sains Dan Praktis, 3(2), 6–13.
  6. Dinkes. (2020). Profil Kesehatan Daerah Istimewa Yogyakarta Tahun 2019. Dinas Kesehatan Daerah Istimewa Yogyakarta.
  7. Fadillah, A., Ramadhani, J., Erlianti, K., & Hasniah. (2021). Analisis Cost of Illness Penyakit Hipertensi di Rumah Sakit Umum Daerah Praya, NTB. Al Ulum Sains Dan Teknologi, 6(2), 104–111.
  8. Katzung BG. (2014). Basic and Clinical Pharmacology (Edisi ke 1). Salemba Medika.
  9. Kemenkes RI. (2018). Riset Kesehatan Dasar; RISKESDAS. Badan penelitan dan pengembangan kesehatan, Kemenkes RI , Jakarta.
  10. Nguyen, T. P. L., Nguyen, T. B. Y., Nguyen, T. T., Vinh Hac, V., Le, H. H., Schuiling-Veninga, C., & Postma, M. J. (2014). Direct costs of hypertensive patients admitted to hospital in Vietnam- a bottom-up micro-costing analysis. BMC Health Services Research, 14, 514.
  11. Nilansari, A. F., Yasin, N. M., & Puspandari, D. A. (2020). Gambaran Pola Penggunaan Obat Antihipertensi Pada Pasien Rawat Inap di RSUD Panembahan Senopati. Lumbung Farmasi, 1(2), 73–79.
  12. Nilansari, A. F., Yasin, N. M., & Puspandari, D. A. (2021). Analisis Tarif INA-CBGs Pasien Hipertensi Rawat Inap di Rumah Sakit Umum Daerah Panembahan Senopati. Jurnal Farmasi Klinik Indonesia, 10(1), 22–29.
  13. Oktadiana, I., Oetari, & Andayani. (2019). Kesesuaian Biaya Riil Terhadap Tarif INA-CBGS pada Pasien Hipertensi di Rumah Sakit Umum Daerah Pandan Arang Boyolali Tahun 2017. Jurnal Farmasi Indonesia, Vol 16 No 2 (2019): Jurnal Farmasi Indonesia, 105–117.
  14. Oyando, R., Njoroge, M., Nguhiu, P., Kirui, F., Mbui, J., Sigilai, A., Bukania, Z., Obala, A., Munge, K., Etyang, A., & Barasa, E. (2019). Patient costs of hypertension care in public health care facilities in Kenya. The International Journal of Health Planning and Management, 34(2), e1166–e1178. https://doi.org/10.1002/hpm.2752
  15. Paczkowska, A., Koligat, D., Nowakowska, E., Hoffmann, K., & Bryl, W. (2014). Analysis of direct costs of hypertension treatment among adolescents in Poland. Acta Poloniae Pharmaceutica, 71(1), 197–203.
  16. Pangaribuan, L., & Lolong, D. B. (2015). Hubungan Penggunaan Kontrasepsi Pil dengan Kejadian Hipertensi Pada Wanita Usia 15-49 Tahun di Indonesia Tahun 2013 (Analisis Data Riskesdas 2013). Media Litbangkes, 25(2), 1–8.
  17. Park, C., Wang, G., Ng, B. P., Fang, J., Durthaler, J. M., & Ayala, C. (2020). The uses and expenses of antihypertensive medications among hypertensive adults. Research in Social and Administrative Pharmacy, 16(2), 183–189. https://doi.org/https://doi.org/10.1016/j.sapharm.2019.05.002
  18. Peacock, F., Amin, A., Granger, C. B., Pollack, C. V, Levy, P., Nowak, R., Kleinschmidt, K., Varon, J., Wyman, A., & Gore, J. M. (2011). Hypertensive heart failure: patient characteristics, treatment, and outcomes. The American Journal of Emergency Medicine, 29(8), 855–862.
  19. Putri, L. S. A., & Satriyasa, B. K. (2019). Gambaran Pola Penggunaan Obat Antihipertensi pada Pasien Hipertensi di Instalasi Rawat Inap RSUP Sanglah Denpasar Tahun 2016. Jurnal Medika Udayana, 8(6), 1–8.
  20. Rosiyani, E. A., Witcahyo, E., & Herawati, Y. T. (2021). Perhitungan Cost of Illness (COI) Pasien Hipertensi di Pelayanan Rawat Inap RSD Balung Kabupaten Jember. Jurnal Ilmu Kesehatan Masyarakat Berkala, 3(2), 117–122.
  21. Sugiyono. (2012). Metode Penelitian Kuantitafif dan R&D. Alfabeta.
  22. Sulistiyono, L., & Kurniawan, A. (2018). Efisiensi Pengelolaan Tempat Tidur Rawat Inap Per Bulan Berdasarkan Indikator Barber Johnson di RSUI Yakssi Gemolong Sragen 2017. Jurnal Ilmiah Rekam Medis Dan Informatika Kesehatan, 8(2), 55–69.
  23. Utama, Y. A., & Nainggolan, S. S. (2022). Faktor Resiko yang Mempengaruhi Kejadian Stroke: Sebuah Tinjauan Sistematis. Jurnal Ilmiah Universitas Batanghari Jambi, 22(1), 549–553.
  24. WHO. (2020). WHO technical specifications for automated non-invasive blood pressure measuring devices with cuff. World Health Organization.
  25. Zawudie, A. B., Lemma, T. D., & Daka, D. W. (2020). Cost of Hypertension Illness and Associated Factors Among Patients Attending Hospitals in Southwest Shewa Zone, Oromia Regional State, Ethiopia. ClinicoEconomics and Outcomes Research : CEOR, 12, 201–211. https://doi.org/10.2147/CEOR.S241591